Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) is one of the most promising low-cost stocks to buy now. On February 3, Ultragenyx Pharmaceutical announced positive long-term data for UX111, which is an ...
Detailed price information for Amphastar Pharma (AMPH-Q) from The Globe and Mail including charting and trades.
Ozempic patent expiry has triggered a fresh pharma race in India. Sun Pharma, Cipla, and Dr Reddy’s are among 7 players ...
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the generic pharmaceuticals stocks, including Amneal (NASDAQ:AMRX) and its peers.
Trade Brains on MSN
Pharma stocks: Which company is likely to lead India's weight-loss injection market?
India, March 23 -- India's semaglutide market has seen heightened competition, with the expiration of the patent causing a flood of generics at discounted prices. The prices vary between Rs 1,290 and ...
The 4 generic pharmaceuticals stocks we track reported a mixed Q4. As a group, revenues beat analysts’ consensus estimates by 2.4%. Amidst this news, share prices of the companies have had a rough ...
The Contract Development and Manufacturing Organization (CDMO) industry in India is a fast-growing segment of the ...
On February 7, Richard Bernstein, CEO of Richard Bernstein Advisors, joined ‘The Exchange’ on CNBC to discuss the state of equity markets, assessing which stocks are growing fast and trading cheaply.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results